By Adam Pick on July 20, 2012
As we continue to track and discuss the medical technologies that are impacting heart valve therapy, I just learned that Medtronic recently began patient enrollment in a unique study that will examine the performance of its CoreValve transcatheter aortic valve replacement device in ‘intermediate risk’ patients.
By Adam Pick on March 6, 2012
I just received an interesting question from Jon about the durability of heart valve replacement devices. He writes, “Adam – I know that the bulk of your patient questions are in regard to upcoming surgeries. But, for those of us who have already had surgeries — like myself who had aortic valve replacement two years ago and I’m 60 years old now — what does my future look like? I was told that my bovine replacement would last 10, 15 or even 20 years. Will my future replacement be identical to the same surgery? Or, will I be looking at something else? Thanks, Jon”
By Adam Pick on February 22, 2012
In connection with yesterday’s post, I received many interesting questions about the SAPIEN aortic valve replacement. For example, Bernard asked about the possibility of a “valve-in-valve” procedure. In his email, Bernard wrote, “My surgeon used a bovine tissue valve to replace my diseased aortic valve. If my new valve requires replacement in the future, can the SAPIEN be used?”
By Adam Pick on February 21, 2012
I just received an interesting question from Anita about the SAPIEN heart valve replacement.
By Adam Pick on February 1, 2012
Earlier this week, the 48th annual Society of Thoracic Surgeons Meeting (STS) was held in Fort Lauderdale, Florida. During the meeting, cardiac surgeons from around the world gather to discuss the latest strategies for optimal cardiac treatment — including heart valve repair and heart valve replacement procedures.
By Adam Pick on December 20, 2011
Like many of you, I’m fascinated by the possibilities of medical technology.
By Adam Pick on November 28, 2011
Recently, Jim sent me a great question that reads, “Adam – I’m 65 and diagnosed with moderate aortic valve stenosis. It seems there are a couple of different types of minimally invasive surgery. Can you help me understand that better?” (To learn more about aortic stenosis, click here.)
By Adam Pick on November 17, 2011
In case you missed it… Some very interesting reports came out about the SAPIEN, a non-invasive aortic valve replacement for patients with aortic stenosis that just received FDA approval for inoperable patients, at the recent Transcatheter Cardiovascular Therapeutics conference in San Francisco.
Heart Valve Summit Video #4: “Why Are The New Transcatheter Therapies Only For Inoperable Patients?” Asks Cory
By Adam Pick on November 7, 2011
As we learned last Thursday, the FDA just approved the new SAPIEN transcatheter aortic valve replacement for inoperable patients. This exciting announcement has left many patients and caregivers wondering why the SAPIEN is only for inoperable patients in the United States.
Special Technology Update: FDA Approves First Transcatheter Aortic Valve Replacement Therapy For “Inoperable” Patients
By Adam Pick on November 3, 2011
Big, big, big, biggggggg news everybody!